Market Size of Global Ceftiofur Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 5.60 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Ceftiofur Market Analysis
The Ceftiofur market studied was anticipated to grow with a CAGR of 5.6% during the forecast period.
COVID-19 has affected the ceftiofur market significantly. The supply chain was disrupted, leading to difficulty in moving animal products, such as meat, milk, and eggs to markets. However, to cater to the disrupted demand-supply chain, the Food and Agriculture Organization, in April 2020, published a new policy regarding the production of livestock and the supply chain of livestock products during the pandemic to ensure sufficient production of livestock. In May 2020, Animal Health Europe announced the European Commission adding veterinary medicines to the ''Communication for the Implementation of the Green Lanes under the Guidelines for Border Management Measures'', to protect health and ensure the availability of goods and essential services for the stable supply of safe, nutritious food and protection of pets during the pandemic. Therefore, the market studied was affected largely by lockdowns and restrictions.
The major factor attributing to the growth of the market is a rise in the death rate among swine and cattle around the world with reproductive tract infections, and skin and soft tissue infections.
Higher demand for ceftiofur antibiotics can be due to their approval for treatment of bacterial respiratory disease associated with various bacterium. These bacteria include Actinobacillus pleuropneumoniae and Streptococcus suis infections among swine, Mannheimia haemolytica, and Haemophilus Somnus among cattle. According to the United States Department of Agriculture's Animal and Plant Health Inspection Service article about National Veterinary Services Laboratories Foreign Animal Disease Diagnostic Laboratory (FADDL), updated in June 2021, several infectious foreign animal disease (FAD) agents are studied in the facility in New York. The Diagnostics Services section of the FADDL can diagnose more than thirty exotic animal diseases (including foot-and-mouth disease, classical swine fever, African swine fever, and other diseases listed by the World Organization for Animal Health) and can perform thousands of diagnostic tests each year. With the help of diagnostics in veterinary, more infectious diseases are being detected which is contributing to the market growth, as it will open new opportunities for treatment options for such diseases.
Ceftiofur Industry Segmentation
As per the scope of this report, Ceftiofur is a third generation cephalosporin antibiotic that act by anti bacterial activity by binding to penicillin-binding proteins (PBPs) on the bacterial cell wall and inactivating them. It is approved for use in veterinary medicine. The Ceftiofur market is segmented by Drug Type (Ceftiofur Sodium, Ceftiofur Hydrochloride, Ceftiofur Crystalline Free Acid), Animal Type (Cattle, Horse, Swine, Others), Application (Respiratory Infections, Urinary Tract Infections, Bovine Interdigital Necrobacillosis, Others), Geography (North America, Europe, Asia-Pacific, Rest of the World). The report offers the value (in USD million) for the above segments.
Drug Type | |
Ceftiofur Sodium | |
Ceftiofur Hydrochloride | |
Ceftiofur Crystalline Free Acid |
Animal Type | |
Cattle | |
Horse | |
Swine | |
Others |
Application | |
Respiratory Infections | |
Urinary Tract Infections | |
Bovine Interdigital Necrobacillosis | |
Others |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
Rest of the World |
Global Ceftiofur Market Size Summary
The ceftiofur market is poised for growth, driven by increasing demand for antibiotics to combat infections in swine and cattle. The market has experienced disruptions due to the COVID-19 pandemic, which affected supply chains and the movement of animal products. However, initiatives by organizations like the Food and Agriculture Organization and Animal Health Europe helped mitigate these challenges by ensuring the continued supply of veterinary medicines. The rise in infectious diseases among livestock, coupled with advancements in veterinary diagnostics, has created new opportunities for ceftiofur, particularly in treating bacterial respiratory diseases in swine and cattle. The swine segment is expected to dominate the market, supported by heightened awareness of animal health and the demand for protein-rich foods.
North America is anticipated to maintain a significant market share, fueled by increased pet adoption and higher animal healthcare spending. The prevalence of animal diseases and injuries further propels market growth in the region. The market is moderately competitive, with major players like Zoetis, Merck & Co., and Ceva Sante Animale leading the way. These companies are actively developing new products to enhance market offerings. The ceftiofur market's growth is also supported by rising awareness and expenditure on animal health, indicating a promising future for the industry.
Global Ceftiofur Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Prevalence of Bovine Respiratory Disease and Swine Bacterial Pneumonia
-
1.2.2 Favorable Initiatives by Government Authorities and Rising Awareness among Livestock Producers
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Medication and Treatment Procedures
-
1.3.2 Higher Risk of Adverse Effects Associated with these Antibiotics
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size - Value in USD million)
-
2.1 Drug Type
-
2.1.1 Ceftiofur Sodium
-
2.1.2 Ceftiofur Hydrochloride
-
2.1.3 Ceftiofur Crystalline Free Acid
-
-
2.2 Animal Type
-
2.2.1 Cattle
-
2.2.2 Horse
-
2.2.3 Swine
-
2.2.4 Others
-
-
2.3 Application
-
2.3.1 Respiratory Infections
-
2.3.2 Urinary Tract Infections
-
2.3.3 Bovine Interdigital Necrobacillosis
-
2.3.4 Others
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United states
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Rest of the World
-
-
Global Ceftiofur Market Size FAQs
What is the current Global Ceftiofur Market size?
The Global Ceftiofur Market is projected to register a CAGR of 5.60% during the forecast period (2024-2029)
Who are the key players in Global Ceftiofur Market?
Hipra, Zoetis Inc., Merck & Co., Inc., (MSD Animal Health), Ceva Sante Animale and Hester Biosciences Limited are the major companies operating in the Global Ceftiofur Market.